TearLab Corporation Reports Second Quarter and First Half 2017 Financial Results
Aug 14, 2017 20:01 pm UTC| Business
SAN DIEGO, Aug. 14, 2017 -- TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) (“TearLab” or the “Company”) today reported its consolidated financial results for the second quarter ended June 30, 2017. All dollar amounts are...
Diffusion Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business Update
Aug 14, 2017 20:01 pm UTC| Business
CHARLOTTESVILLE, Va., Aug. 14, 2017 -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on the development of novel small molecule therapeutics...
ParkerVision Reports Second Quarter 2017 Results
Aug 14, 2017 20:01 pm UTC| Business
JACKSONVILLE, Fla., Aug. 14, 2017 -- ParkerVision, Inc. (NASDAQ:PRKR), a developer and marketer of semiconductor technology solutions for wireless applications, today announced results for the three and six months ended...
Trevena Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Aug 14, 2017 20:01 pm UTC| Business
CHESTERBROOK, Pa., Aug. 14, 2017 -- Trevena, Inc. (NASDAQ:TRVN) today announced that the independent Compensation Committee of the Board of Directors of the Company approved, effective as of July 31, August 7, and...
Forward Reports Fiscal 2017 Third Quarter Results
Aug 14, 2017 20:01 pm UTC| Business
WEST PALM BEACH, Fla., Aug. 14, 2017 -- Forward Industries, Inc. (NASDAQ:FORD), a designer and distributor of custom carry and protective solutions, today announced financial results for its third fiscal quarter ended...
Fate Therapeutics Reports Second Quarter 2017 Financial Results
Aug 14, 2017 20:01 pm UTC| Business
First Subject Treated with FATE-NK100 in VOYAGE for Acute Myelogenous Leukemia FDA Clears Investigational New Drug Applications for FATE-NK100 in Recurrent Ovarian Cancer and in Advanced Solid Tumors with Monoclonal...
Reata Pharmaceuticals, Inc. Announces Second Quarter 2017 Financial and Operating Results
Aug 14, 2017 20:01 pm UTC| Business
IRVING, Texas, Aug. 14, 2017 -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA) (“Reata” or “the Company”), a clinical-stage biopharmaceutical company, today announced financial results for the second quarter ended June 30,...